Jason P Rhodes's Net Worth

Jason P Rhodes's net worth is estimated to be at least $67,229,099.97 as of 11/08/2024. CoreStreet's estimation of Jason P Rhodes's net worth is based on their sale of stock and current holding of stock.

Jason P Rhodes is Director at Dyne Therapeutics Inc. They have executed at least 25 trades of stock as per SEC Form 4 filings. Their most recent trade was for 190,920 units of DYN stock on 02/28/2024. Their biggest sale was on 02/26/2024 when they sold 248,219 units of Dyne Therapeutics Inc stock for $5,887,754.68. They typically trade 4 times per year.

Total value of insider buys:
  • $25,022,316.70
Total value of insider sells:
  • $42,206,783.27
Most recent insider trade:
  • Feb. 28, 2024

Jason P Rhodes's Insider Trading History

Dyne Therapeutics IncTitleAmountPriceTypeTotal Value
Feb. 28, 2024
Director190,920$24.84Sell$4,742,452.80
Feb. 26, 2024
Director248,219$23.72Sell$5,887,754.68
Feb. 22, 2024
Director119,360$22.66Sell$2,704,697.60
Feb. 20, 2024
Director169,539$22.72Sell$3,851,926.08
Feb. 15, 2024
Director177,906$23.89Sell$4,250,174.34
Dec. 12, 2022
Director934,581$10.70Buy$10,000,016.70
Generation Bio CoTitleAmountPriceTypeTotal Value
Sept. 29, 2021
Director16,586$24.59Sell$407,849.74
Sept. 27, 2021
Director51,389$25.70Sell$1,320,697.30
Sept. 24, 2021
Director28,916$25.84Sell$747,189.44
Sept. 22, 2021
Director30,617$25.89Sell$792,674.13
June 23, 2021
Director62,609$25.36Sell$1,587,764.24
June 21, 2021
Director63,892$24.84Sell$1,587,077.28
April 14, 2021
Director23,413$26.61Sell$623,019.93
April 12, 2021
Director74,124$26.15Sell$1,938,342.60
April 8, 2021
Director43,550$28.50Sell$1,241,175.00
Replimune Group IncTitleAmountPriceTypeTotal Value
Dec. 18, 2020
Director4,319$41.95Sell$181,182.05
Dec. 16, 2020
Director12,675$42.13Sell$533,997.75
Dec. 14, 2020
Director37,659$43.49Sell$1,637,789.91
Dec. 11, 2020
Director31,636$43.38Sell$1,372,369.68
Dec. 9, 2020
Director41,216$43.77Sell$1,804,024.32
Dec. 7, 2020
Director67,890$45.96Sell$3,120,224.40
Nov. 18, 2019
Director1,100,000$13.61Buy$14,971,000.00
Nov. 15, 2019
CEO15,000$3.42Buy$51,300.00
Epizyme IncTitleAmountPriceTypeTotal Value
Aug. 4, 2014
CFO30,000$29.74Sell$892,200.00
July 7, 2014
CFO30,000$32.74Sell$982,200.00